Archive for Junio, 2009

Judge To Hear Arguments On S.D. Abortion Law Requiring Statement That Procedure Ends Human Life

Martes, Junio 30th, 2009

A federal judge will hear oral arguments on July 17 regarding a lawsuit challenging a South Dakota law that requires doctors to tell women seeking abortions that the procedure will end a human life, the AP/Sioux City Journal reports. Planned Parenthood, which operates the states only abortion clinic, appealed the law after it was passed in 2005. U.S. District Judge Karen Schreier temporarily prevented the law from going into effect, but the 8th U.S. Circuit Court of Appeals in July 2008 overruled that order, and the state began enforcing the law. According to the AP/Journal, Schreier will decide during the hearing whether to grant motions for summary judgment and will consider Planned Parenthoods request to stop the state from imposing sanctions over the laws requirements (AP/Sioux City Journal, 6/26).

Reprinted with kind permission from nationalpartnership.org. You can view the entire Daily Womens Health Policy Report, search the archives, or sign up for email delivery here. The Daily Womens Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2009 The Advisory Board Company. All rights reserved.

Patients With Rheumatoid Arthritis Who Had Poor Response To Other Drugs Could Have Better Results With Golimumab

Lunes, Junio 29th, 2009

An article published Online First and in this weeks edition of

Global AIDS Coordinator Goosby Discusses Slowing Spread Of Disease Among Pregnant Women

Lunes, Junio 29th, 2009

Eric Goosby, U.S. global AIDS coordinator and administrator of the Presidents Emergency Plan for AIDS Relief, said that slowing the spread of HIV among pregnant women is one of his top priorities, the San Francisco Chronicle reports. In an interview with the Chronicle, Goosby said he also plans to focus U.S. global efforts on education and prevention, as well as convincing other nations to increase their involvement in the fight against HIV/AIDS. Although Goosby stressed the importance of indentifying people who could benefit from antiretroviral drugs, he added that “[w]ere not going to be able to treat ourselves out of the epidemic, and prevention efforts will need to be continued and increased.” He continued, “We also need to look for concentration of patients who have a higher probability of HIV infection, such as pregnant women getting them tested, getting them on antiretrovirals, which will prevent transmission to the fetus.” Goosby estimated that only around 35% of pregnant women who are HIV positive and could benefit from antiretrovirals receive the drugs.

Goosby also praised the efforts of PEPFAR, which was established six years ago under former President George W. Bush. However, he said that more work must be done and that the disease is not controlled. SubSaharan Africa, where about 23 million people are living with HIV, “is clearly the epicenter on the planet of this epidemic,” Goosby said. He also noted that HIV/AIDS has begun to spread more rapidly among certain populations in Russia, Ukraine, China and Southeast Asia (Doyle, San Francisco Chronicle, 6/24).

Reprinted with kind permission from nationalpartnership.org. You can view the entire Daily Womens Health Policy Report, search the archives, or sign up for email delivery here. The Daily Womens Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2009 The Advisory Board Company. All rights reserved.

Cimzia(R), The Only PEGylated Anti-TNF, Recommended For Approval In The EU For Rheumatoid Arthritis

Viernes, Junio 26th, 2009

UCB announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending that the European Commission grants a marketing authorisation for Cimzia® (certolizumab pegol), in combination with methotrexate (MTX), for the treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to diseasemodifying antirheumatic drugs (DMARDs) including MTX, has been inadequate. In these patients, Cimzia® can be given as monotherapy in case of intolerance to MTX or when continued treatment with MTX is inappropriate. Cimzia® has been shown to reduce the rate of progression of joint damage as measured by Xray and to improve physical function, when given in combination with MTX.

The recommendation has been granted for Cimzia® to be administered as a subcutaneous injection using the prefilled syringe.

“The CHMP positive opinion is a significant milestone for UCB, but especially for people suffering from rheumatoid arthritis,” said Roch Doliveux, Chief Executive Officer of UCB. “Cimzia® can provide an additional effective treatment option for patients with this debilitating condition, helping them to lead fuller lives.”

The European Commission usually delivers a European marketing authorisation subsequent to a positive CHMP opinion within three months. Following European marketing authorisation the first launches of Cimzia®, in the European Union, are anticipated before the end of 2009.

The CHMP decision is supported by data from a comprehensive clinical development programme, involving more than 2 300 patients with RA and over 4 000 patientyears experience.

In the pivotal clinical trials, reported serious adverse reactions, as with other antiTNFs, included infections (including tuberculosis) and malignancies (including lymphoma), and the most commonly occurring adverse events were upper respiratory tract infections, rash and urinary tract infections. A pooled analysis of the safety data showed a low incidence of injection site pain (1.5%) and a low level of discontinuations due to adverse events (5%). Cimzia® demonstrated a favorable riskbenefit profile in patients with at least up to two years of drug exposure.

Dry Autumns And Winters May Lead To Fewer Tornadoes In The Spring, Says UGA Researcher

Viernes, Junio 26th, 2009

Global warming will likely mean more unpredictable weather, scientists say, and a new study by researchers at the University of Georgia pins down, possibly for the first time, how drought conditions in an areas fall and winter may effect tornado activity the following spring.

The study, published recently in the journal Environmental Research Letters, is specific to Georgia and the Southeast, but further study could reveal patterns that might make this more general including the already tornadoprone Great Plains.

“Our results suggest that there is a statistically significant reduction in tornado activity during a tornado season following drought the preceding fall and winter,” said Marshall Shepherd, a meteorologist and lead author of the study. On the other hand, wet autumns and winters examined in the study had nearly twice as many spring tornado days as drought years did.

The research gives hope that one day meteorologists and climatologists may be able to predict the severity of a spring tornado season the way they now do for hurricanes. Other authors of the paper were Thomas Mote, also of the University of Georgia, and Dev Niyogi of Purdue University. Shepherd and Mote are in department of geography in UGAs Franklin College of Arts and Sciences.

The genesis for the research was the severe Atlanta tornado in March 2008, and Shepherds interest in how tornadoes form during severe drought years.

While such tools as Doppler radar have increased our ability to “see” tornadoes as they form, predicting a tornado seasons potential severity has remained elusive. The Intergovernmental Panel on Climate Change projected in 2007 that the frequency and severity of droughts may increase over time, but very little is known about drought conditions affect the frequency or intensity of severe weather hazards such as tornadoes.

To help understand how fall and winter weather might affect spring tornado seasons, the research team acquired the historical database of severe thunderstorms and tornado occurrences from 19512006 from the Storm Prediction Center of the National Oceanic and Atmospheric Administration. They also analyzed storm data reports from the National Climactic Data Center and meteorological drought conditions using historical rain gauge and Tropical Rainfall Measuring Mission (TRMM) satellite data from the National Aeronautics and Space Administration (NASA).

Using a number of tools of scientific analysis, the team primarily focused on tornado activity from MarchJune in Georgia and the Southeast. What they found was shocking, Shepherd said, yet plausible.

On average, wet autumns and winters presaged nearly twice as many spring tornado days in the study area as prior drought seasons. Springs following wet winters and falls were also five to six times more likely to have multiple tornado days than antecedent drought years.

“We do not suggest that soil moisture or precipitation the previous fall and winter exert a direct control on which individual storms will spawn tornadoes,” said Shepherd. “But these longterm seasonal relationships in the study area are striking.”

Correlating historical records and tornado activity has been difficult at best for scientists over the years. For one thing, the National Weather Service did not implement its watch and warning system until the mid1950s, and only with advent of advanced radar techniques and ground examination of storm sites have researchers been able to say categorically that a certain storm even was a tornado. Also, studies linking tornadic activity with the El Niño cycle have been contradictory.

While it clearly seems that wet falls and winters lead to more severe spring tornado seasons, antecedent seasonal drought scenarios in north Georgia were almost never associated with abovenormal tornadic activity the following spring over the 50years period of the study.

The results for north Georgia were essentially replicated for the larger region encompassing Tennessee, Georgia, Alabama and Mississippi. For this entire region, a stunning 75 percent of years characterized by meteorological drought in falls and winters had belownormal tornado seasons in the spring.

While the new study, which was supported by grants from NASA, offers strong clues about how spring tornado seasons form, the authors urge caution in interpreting the findings until the analysis is repeated for other locations.

Just how the connection works between fallwinter rainfall and spring tornado seasons remains unclear. One possibility is that the atmosphere uses soil moisture “memory” from the fall and winter to modify conditions suitable for severe weather. A related hypothesis is related to “soil moisture” pockets and storm initiation.

Source
Marshall Shepherd

Sociologists To Explore The New Politics Of Community In San Francisco Aug. 7-11

Jueves, Junio 25th, 2009

More than 5,000 sociologists will convene in San Francisco this August to explore ideas and scientific research about how community affects contemporary social issues as part of the American Sociological Associations 104th annual meeting.

In addition to three plenary sessions featuring leading sociological minds, a minisymposium will examine how the election of Barack Obama might signal a refreshed spirit of community activism and involvement. More than 200 additional sessions will feature the latest sociological research and perspectives from the leading minds in social science.

WHAT The American Sociological Associations 104th Annual Meeting “The New Politics of Community”

WHEN Friday, Aug. 7, through Tuesday, Aug. 11, 2009

WHERE Hilton San Francisco and Parc 55 HotelSan Francisco, Calif.

MAJOR PLENARY SESSIONS

+ Building Excellent, Diverse and Just Communities A Conversation Among Artists, Academics and Activists
Friday, Aug. 7, 700 900 p.m.
A distinguished and diverse panel will address the connections between social justice and communitybuilding, discussing the needs of contemporary and future communities with a special focus on youth.

+ Why Obama Won (and What that Says About Democracy and Change in America)
Saturday, Aug. 8, 1230 215 p.m.
Social scientists examine the potential for change the oftused buzzword of the Obama campaign in the postelection era, taking into account new forms of political engagement; the changing American population; and the revitalization of democratic institutions. Panelists will discuss the actual and potential significance of Barack Obamas victory.

+ Bringing Communities Back In Setting a New Policy Agenda
Monday, Aug. 10, 1230 215 p.m.
Given the influence of social networks on individual actions and beliefs, prominent sociologists discuss how sociologys conception of communities can assist in the development of public policies that effectively address social problems.

ADDITIONAL SESSIONS OF INTEREST

MiniSymposium on the Social Significance of Barack Obama
+ A Defining Moment? Youth, Power and the Obama Phenomenon
Saturday, Aug. 8, 1030 a.m. 1210 p.m.

+ Through the Lens of Gender, Race, Sexuality and Class The Obama Family and the American Dream
Sunday, Aug. 9, 1030 a.m. 1210 p.m.

+ Understanding Democratic Renewal The Movement to Elect Barack Obama
Sunday, Aug. 9, 830 a.m. 1010 a.m.

+ The Future of Community Organizing During an Obama Presidency
Sunday, Aug. 9, 230 p.m. 410 p.m.

+ AsianAmerican Movements, Identities and Politics A New Racial Project in the Obama Years?
Saturday, Aug. 8, 430 p.m. 610 p.m.

Selected Author Meets Critics Sessions + Black on the Block The Politics of Race and Class in the City by Mary E. Pattillo
Sunday, Aug. 9, 230 p.m. 410 p.m.

+ God Needs No Passport Immigrants and the Changing Religious Landscape by Angie Y. Chung
Saturday, Aug. 8, 430 p.m. 610 p.m.

+ Opting Out Why Women Really Quit Careers and Head Home by Pamela Stone
Saturday, Aug. 8, 1030 a.m. 1210 p.m.

+ Shopping for Safety How We Changed from Protecting the Environment to Protecting Ourselves by Andrew Szasz
Monday, Aug. 10, 230 p.m. 410 p.m.

+ Toxic Exposures Contested Illnesses and the Environmental Health Movement by Phil Brown
Saturday, Aug. 8, 230 p.m. 410 p.m.

+ Wont You Be My Neighbor Race, Class and Residence in Los Angeles by Camille Zubrinsky Charles
Tuesday, Aug. 11, 1030 a.m. 1210 p.m.

Visit asanet.org/cs/meetings/2009 for the meetings searchable preliminary program and additional details.

Source
Jackie Cooper

Free Mammograms Available Through Minnesota Department Of Health - Newly Enrolled Women Will Also Receive A $20 Bonus

Miércoles, Junio 24th, 2009

The Minnesota Department of Health (MDH) will offer free mammograms through a televised phone bank on FOX 9 KMSPTV in Minneapolis on Thursday, June 25, 2009. The phone bank will air during the 5 p.m., 530 p.m., 9 p.m. and 10 p.m. newscasts. The mammograms are offered through the Sage Screening Program, a state and federally funded program that provides free breast and cervical cancer screenings to uninsured and underinsured women age 40 and older. Newly enrolled women in the program will also receive $20 for being screened, which has been shown to increase screening rates.

Messages stressing the importance of detecting breast cancer early and encouraging women to take advantage of the screening program will also run throughout the campaign. MDHs tollfree number, 18886HEALTH will be answered from 8 a.m. to 1035 p.m. on June 25 and 8 a.m. 5 p.m. all other weekdays. Voice messages can be left anytime outside of these hours.

Through this event, MDH hopes to make more women in Minnesota aware of this free program. “We think many women are not receiving these lifesaving screening tests because they have no health insurance or their insurance has deductibles or copayments they cannot meet. Sage can help,” said Jonathan Slater, chief of Cancer Control at MDH.

Sage has a network of more than 400 local health care providers statewide, and has served nearly 114,000 women since 1991. Approximately 1,400 women have been diagnosed and treated for breast and cervical cancer through the Sage program.

This year, it is estimated that 3,500 Minnesotan women will be diagnosed with breast cancer and approximately 650 Minnesota women will die from the disease. Annual mammography has been reported to reduce breast cancer deaths in women age 40 and older by detecting the disease in its earliest stages when it is most easily treated.

Women seeking eligibility information about the free mammography programor women who want to make an appointment for a free mammogramshould call Sage at 18886HEALTH (18886432584). Women living in neighboring states or whose incomes exceed Sages guidelines, should call the American Cancer Society at 18002272345 to learn of other free and lowcost programs.

Would You Know What To Do In A Mental Health Emergency?

Martes, Junio 23rd, 2009

A quarter of us will experience at least one mental health problem in any one year, and yet stigma and prejudice are still widespread.

In recognition of this hidden health crisis, The Royal Society for Public Health (RSPH rsph.org.uk ) has today accredited the Mental Health First Aid (MHFA) training programme in England, developed to establish a network of people with the skills and knowledge to take this essential first aid training into the community.

Mental health problems can affect people at any time, in different ways, and many suffer in silence for a long time before eventually seeking help. The MHFA course trains people to recognise the symptoms of mental health problems, shows how to offer initial help to those affected, and provides information about professional support.

MHFA supports the governments wellbeing agenda which highlights the importance of early intervention. Trainees on mental health first aid courses work in many different settings, including commercial organisations, teaching, police and prison services.

Fionuala Bonnar, programme director for Mental Health Services and Improvement, London Development Centre, part of Commissioning Support for London, said “The MHFA course instructors are a vital link in our work to promote awareness of mental health problems. RSPH accreditation for our instructors programme shows that our courses are delivered to the RSPHs very high standards, giving additional confidence to instructors, trainees and the public.”

RSPH chief executive professor Richard Parish comments “Many people are familiar with first aid for physical health, but there is a much more limited understanding of first aid for mental health. Early recognition of mental health problems can make all the difference to the outcome for individuals and their families, and the mental health first aid course gives trainees the practical knowledge to help identify anyone who may need professional help. Excellent training for these instructors is essential to the success of this much needed work. RSPH accreditation confirms the high quality of the instructor training programme and I congratulate all those involved in achieving this recognition.”

Notes

1. The National Mental Health Development Unit (NMHDU)

MHFA was originally developed in Australia and has been adapted for use in England by NMHDU. More than 100 MHFA instructors have now been trained.

What Is Psychology? What Are The Branches Of Psychology?

Lunes, Junio 22nd, 2009

Psychology is the science of the mind and behavior. The word “psychology” comes from the Greek word psyche meaning “breath, spirit, soul”, and the Greek word logia meaning the study of something. According to Medilexicons medical dictionary, psychology is “The profession (clinical psychology), scholarly discipline (academic psychology), and science (research psychology) concerned with the behavior of humans and animals, and related mental and physiologic processes.” Although psychology may also include the study of the mind and behavior of animals, in this article psychology refers mainly to humans.How do psychologists study the mind? The mind is highly complex and enigmatic. Many wonder how psychologists can study such an intricate, seemingly abstract and extremely sophisticated thing. Even if scientists look inside the brain, as in an autopsy or during a surgical operation, all they see is gray matter (the brain). Thoughts, cognition, emotions, memories, dreams, perceptions, etc. cannot be seen physically, like a skin rash or heart defect.

Experts say that the approach to psychology is not that different to other sciences. As in other sciences, experiments are devised to confirm or disprove theories or expectations. For a physicist, the raw data during the experiments may be atoms, electrons, the application or withdrawal of heat, while for the psychologist human behavior is the raw data.

See our specialized news channels

Psychology / Psychiatry news

Attention Deficit Hyperactive Disorder (ADHD) news

Alzheimers / Dementia news

Anxiety / Stress news

Autism news

Bipolar disorder news

Depression news

Dyslexia news

Eating disorders news

Mental health news

Neurology news

Schizophrenia news

For a psychologist, human behavior is used as evidence or at least an indication of how the mind functions. We are unable to observe the mind directly; however, virtually all our actions, feelings and thoughts are influenced by the functioning of our minds. That is why human behavior is used as raw data for testing psychological theories on how the mind functions.Where does psychology lie compared to other sciences? Many say that psychology lies at the crossroads of other disciplines, such as medicine, linguistics, sociology, biology, artificial intelligence, anthropology, sociology, and even history. For example, neuropsychology which looks at how different brain areas are involved in memory, language, emotions, etc. overlaps with biology and medicine.How many branches of psychology are there? There are many branches of psychology; how you split them up will usually depend on which part of the world you are, even which university or institution you were trained at. The following are seen as the main branches of psychologyClinical psychology integrates science, theory, and practice in order to understand, predict and relieve maladjustment, disability, and discomfort. Clinical psychology also promotes adaption, adjustment and personal development. A clinical psychologist concentrates on the intellectual, emotional, biological, psychological, social, and behavioral aspects of human performance throughout a persons life, across varying cultures and socioeconomic levels. In other words, clinical psychology is the scientific study and application of psychology in order to understand, prevent, and alleviate psychologicallycaused distress or dysfunction (disability) and promote the patients wellbeing and personal development.

Psychological assessment and psychotherapy are central to the practice of clinical psychology. However, clinical psychologists are often also involved in research, training, forensic testimony, and other areas.
Cognitive psychology this branch investigates internal mental processes, such as problem solving, memory, learning, and language (how people think, perceive, communicate, remember and learn). This branch of psychology is closely related to other disciplines, such as neuroscience, philosophy and linguistics.

Other interesting articles

What is ADHD (attention deficit hyperactive disorder)

What is anorexia? What is bulimia?

What is anxiety? Anxiety symptoms and causes.

What is autism? What causes autism?

What is bipolar disorder?

What is dementia? What causes dementia? What are the symptoms of dementia?

What is depression? What causes depression?

What is dyspraxia? How is dyspraxia treated?

What is hypochondria?

What is mental health? What is mental disorder?

What is schizophrenia?At the center of cognitive psychology is how people acquire, process and store information. Many say that cognitive psychology is the study of intelligence. Practical applications for cognitive research may include how to improve memory, increase the accuracy of decisionmaking, or how to set up educational programs to boost learning.
Developmental psychology this is the scientific study of systematic psychological changes that a person experiences over the course of his/her life span. Developmental psychology is often referred to as human development. It used to just focus on infants and young children, but also includes teenagers and adults today the whole human life span. Developmental psychology includes any psychological factor that is studied over the life of a person, including motor skills, problem solving, moral understanding, acquiring language, emotions, personality, selfconcept and identity formation.

Developmental psychology also looks and compares innate mental structures against learning through experience. For example, babies are thought to be born with an LAD (language acquisition device) an inbuilt ability to acquire language. A developmental psychologist will be interested in how the LAD works compared to the babys development through experience, and how the two interplay. A developmental psychologist will be interested in how a persons characteristics interact with environmental factors and how development is impacted. Developmental psychology overlaps with several other branches of psychology, as well as other disciplines, such as linguistics.
Evolutionary psychology this looks at how human behavior has been affected by psychological adjustments during evolution. Just as biologists talk about natural selection or sexual selection during evolution, this branch of psychology applies psychology to the same way of thinking. An evolutionary psychologist believes, for example, that language or memory perception are functional products of natural selection.

Some evolutionary psychologists hypothesize that language learning is a capacity we are born with, making language learning a virtually automatic process but not reading or writing. In other words, they believe our ability to learn language is inherited while our ability to read and write is not (language learning will happen automatically, while reading and writing has to be taught). A person who is born in a town that speaks French will speak French by the time he is 20. However, if he is not taught to read he will be illiterate language is acquired automatically if it exists around you, while reading and writing are not.

An evolutionary psychologist believes that our human psychological traits are adaptations for survival in the everyday environment of our ancestors.
Forensic psychology this involves applying psychology to criminal investigation and the law. A forensic psychologist practices psychology as a science within the criminal justice system and civil courts. Forensic psychology involves understanding criminal law in the relevant jurisdictions in order to interact with judges, lawyers and other professionals of the legal system. Forensic psychology involves the ability to testify in court, to present psychological findings in legal language to the courtroom, and to provide data to legal professionals in a clear way.

A forensic psychologist needs to understand the rules, standards, and philosophy of his/her countrys judicial system.
Health psychology also called behavioral medicine or medical psychology. This branch observes how behavior, biology and social context influence illness and health. While a doctor treats the illness, the health psychologist will focus more on the person who has the illness, by finding out about their socioeconomic status and background, behaviors that may have an impact on the disease (such as medication compliance), plus the biological reasons for the illness. The aim of the health psychologist is to improve the patients overall health by analyzing disease in the context of biopsychosocial factors. Biopsychosocial refers to the biological, psychological, and social aspects in contrast to the strictly biomedical aspects of disease.

Health psychologists generally work alongside other medical professionals in clinical settings.
Neuropsychology studies the structure and function of the brain in relation to clear behaviors and psychological processes. Neuropsychology is also involved in lesion studies in the brain, as well as recording electrical activity from cells and groups of cells in higher primates, including some human studies.

A neuropsychologist will use a Neuropsychological Evaluation a systematic assessment procedure to determine the degree of any possible behavioral problems following suspected or diagnosed brain injury in a patient. When diagnosis is made, some patients are treated with an individualized cognitive remediation protocol a treatment that helps the patient overcome his/her cognitive deficits.
Occupational psychology (also known as industrialorganizational psychology, IO psychology, work psychology, organizational psychology, work and organizational psychology, occupational psychology, personnel psychology or talent assessment) studies the performance of people at work and in training, develops an understanding of how organizations function and how people and groups behave at work. The occupational psychologist aims to increase effectiveness, efficiency, and satisfaction at work.

The British Psychological Society says occupational psychology “is concerned with the performance of people at work in training, how organizations function and how individuals and small groups behave at work. The aim is to increase the effectiveness of the organization, and to improve the job satisfaction of the individual.”
Social psychology uses scientific methods to understand and explain how feeling, behavior and thoughts of people are influenced by the actual, imagined or implied presence of other people. A social psychologist will look at group behavior, social perception, nonverbal behavior, conformity, aggression, prejudice, and leadership. Social perception and social interaction are seen as key to understanding social behavior.

Put simply, social psychology studies the impact of social influences on human behavior. A short history of psychologyIn a philosophical context psychology was around thousands of years ago in ancient Greece, Egypt, India, Persia and China. Medieval Muslim psychologists and doctors had a more clinical and experimental approach to psychology they were the first to have psychiatric hospitals.

Pierre Cabanis (France) created biological psychology in 1802. A physiologist, Cabanis wrote a well known essay called “Relations between the physical and moral aspects of man” (”Rapports du physique et du moral de lhomme”). He interpreted the mind according to his previous studies of biology. He believed that sensibility and soul were parts of the nervous system.

1979, the birthdate of psychology In 1979 Wilhelm Wundt, Germany, founded psychology as a truly independent experimental field of study. He set up the first laboratory that carried out psychological research exclusively at Leipzig University. Wundt is known today as the father of psychology.

Principles of Psychology, published by William James, an American philosopher in 1980, was discussed by psychologists worldwide for many decades.

Hermann Abbingaus (18501909), University of Berlin, was the first psychologist to study memory extensively. Ivan Pavlov (18491936), famous today even among lay people for the term Pavlovs dog, researched the learning process called “classical conditioning”.Psychoanalysis Sigmund Freud (18561939), Austria, developed psychoanalysis a method of psychotherapy. His understanding of the mind was mainly based on interpretive methods, introspection and clinical observations. He focused on resolving unconscious conflict, mental distress and psychopathology. Freuds theories on sexuality and the unconscious mind became famous; probably because sexuality was a taboo subject at the time. The main principle of Freuds theory was that the unconscious is responsible for most thought and behavior in everybody and the disorders of the mentally ill. Freud had a considerable influence in psychiatrist Carl Jung (Switzerland).
Structuralism vs. Functionalism E. B Titchener (USA), a student of Wundt, strongly believed in structuralism. William James and John Dewey were strong believers in functionalism. Structuralism is interested in what is consciousness? while functionalism is interested in what is consciousness for? What are the purposes or functions of consciousness and basic mental processes?

Structuralists and functionalists disagreed with each other passionately. Most agree there was never a clear winner in the debate but their discussion did lead to a rapid spread of psychology in the USA, as well as some other parts of the world. Stanley Hall set up the first psychology lab in the United States at Johns Hopkins University.
Behaviorism in 1913 an American psychologist, John B. Watson, founded a new movement that altered the focus of psychology. Watson believed that structuralists and functionalists deviated too much from objective science. Put simply, Watson said that psychology should focus on the study of behavior because he believed that behavior was not the result of internal mental processes, but rather the result of how we respond to stimuli from the environment. Behaviorism focused on how people learn new behavior from the environment. Behaviorism became very popular in the USA. B. F Skinner followed in Watsons footsteps.
Humanism some psychologists viewed behaviorism and psychoanalytic theory as too dehumanizing. Rather than being victims of the environment or the unconscious, humanists said that humans are innately good and that our own mental processes played an active role in our behavior. The humanist movement valued highly our emotions, free will, and a subjective view of experience.
Cognitive Theory this started in the 1970s and is seen as the most recent school of thought in psychology. Cognitive perspective is much more objective and calculating than humanism. However, it differs from behaviorism in that it focuses on mental processes extensively. Cognitive theorists believe that we take in information from our environment through our senses and then process the data mentally by organizing it, manipulating it, remembering it, and relating it to information we had stored previously. Cognitive theory is applied to language, memory, learning, perceptual systems, mental disorders and dreams.
Today dominant movements do not really exist today in the way they used to. Behaviorism, psychoanalytic theory, humanism, and cognitive perspective are all studied currently by psychologists. Psychology has become much more eclectic (selecting what appears to be best from every doctrine, movement or school of thought).

Cephalon Provides Clinical Update On Lestaurtinib In Relapsed Acute Myelogenous Leukemia

Sábado, Junio 20th, 2009

Cephalon, Inc. (Nasdaq CEPH) announced results from a pivotal clinical trial of lestaurtinib (CEP701) in patients with relapsed acute myelogenous leukemia (AML) expressing FLT3 activating mutations. The study was designed to show the benefit of lestaurtinib in this patient population when given in sequence with standard induction chemotherapy compared to those treated with standard induction chemotherapy alone. An analysis of the study showed that patients who were treated with lestaurtinib showed similar rates of complete response but no increased benefit in overall survival, compared to those who received induction chemotherapy alone.

“We are disappointed that this study with lestaurtinib did not demonstrate a benefit for this patient population but we remain committed to oncology clinical research and developing innovative therapies for lifethreatening diseases,” said Dr. Lesley Russell, Executive Vice President and Chief Medical Officer at Cephalon.

The results of this study in relapsed AML will be submitted for presentation at a future medical meeting. The outcome of this study has no impact on the companys previously issued financial guidance for 2009.

“We made a significant financial investment in this pioneering effort to develop lestaurtinib for this molecularly targeted patient population with a poor prognosis and few treatment options,” said Frank Baldino, Jr., Ph.D., Cephalon founder, chairman and CEO. “Patients with lifethreatening diseases need companies like Cephalon to make that investment and take that risk if we are to improve patient outcomes and the overall cost of healthcare.”

Developed by Cephalon scientists, lestaurtinib is a potent inhibitor of several tyrosine kinases including FLT3 and a Janus kinase (JAK2). In leukemic cells, lestaurtinib inhibits FLT3 activity and induces cell death (apoptosis). In myeloproliferative disorders, mutations in JAK2 may play a role in allowing large numbers of abnormal blood cells or platelets to grow and spread in the bone marrow and the rest of the body. Based on its potential to inhibit this activity, lestaurtinib is in ongoing studies for the treatment of myeloproliferative disorders.

About Cephalon Oncology

Cephalon, a leading biopharmaceutical company, is building a diversified portfolio of oncology products that represents a comprehensive approach to extend and enhance the lives of patients with cancer. Cephalon Oncology is a strategic business unit focused on the development and commercialization of oncology products and resources for patients and healthcare providers. The Cephalon Oncology portfolio includes a number of promising investigational and marketed compounds. The therapeutic portfolio in the United States includes two marketed products TREANDA(R) (bendamustine HCl) for Injection, which is approved in the United States for the treatment of chronic lymphocytic leukemia (CLL) and for the treatment of patients with indolent Bcell nonHodgkins lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximabcontaining regimen and TRISENOX(R) (arsenic trioxide) injection, approved for the treatment of patients with relapsed or refractory acute promyelocytic leukemia.

In Europe, Cephalon markets three additional oncology products in 19 countries.

About Cephalon, Inc.

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of many unique products in four core therapeutic areas central nervous system, inflammatory diseases, pain and oncology. A member of the Fortune 1000 and the S&P 500 Index, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the companys headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota.

Cephalon has a growing presence in Europe, the Middle East and Africa. The Cephalon European headquarters and preclinical development center are located in MaisonsAlfort, France, just outside of Paris. Affiliates are located in England, Ireland, France, Germany, Italy, Spain, the Netherlands for the Benelux countries, and Poland for Eastern and Central European countries. Cephalon Europe markets more than 30 products in four areas central nervous system, pain, primary care and oncology.

The companys proprietary products in the United States include NUVIGIL(R) (armodafinil) Tablets [CIV], TREANDA, AMRIX(R) (cyclobenzaprine hydrochloride extendedrelease capsules), FENTORA(R) (fentanyl buccal tablet) [CII], TRISENOX, GABITRIL(R) (tiagabine hydrochloride), PROVIGIL(R) (modafinil) Tablets [CIV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [CII]. The company also markets numerous products internationally.

In addition to historical facts or statements of current condition, this press release may contain forwardlooking statements. Forwardlooking statements provide Cephalons current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, characterizations of its development pipeline, development plans for lestaurtinib, development of potential pharmaceutical products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, sales and earnings guidance, and other statements regarding matters that are not historical facts. You may identify some of these forwardlooking statements by the use of words in the statements such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” or other words and terms of similar meaning. Cephalons performance and financial results could differ materially from those reflected in these forwardlooking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8K, 10Q and 10K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forwardlooking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forwardlooking statements. Furthermore, Cephalon does not intend to update publicly any forwardlooking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.

Source Cephalon, Inc